Genalice is a pioneering brand that specializes in high-volume data processing and analysis for biomarker discovery research. Their unique approach positions them as an important player in this field. Their flagship product, GENALICE MAP, is a cloud-based solution that offers faster alignment of longer indels, making it ideal for large-scale DNA variation studies.

Genalice also provides NGS (Next-Generation Sequencing) data analysis services, including NGS read alignment and population calling. With their high-performance NGS RNA extraction technology, they help researchers stay ahead of the competition in genomics research. The management team of Genalice is comprised of experienced executives in the fields of ICT and Health & Life Sciences, supported by a group of scientific experts, successful entrepreneurs, and senior executives.

Their expertise and network enable them to deliver innovative solutions that address major challenges in biomarker discovery and personalized medicine development